Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-18 | Ultragenyx Pharmaceutical Inc. | Crombez Eric
(EVP and Chief Medical Officer) |
S | Common Stock | D | 142 | $44.10 - $44.10 | $6,262 |
| 2024-04-16 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
F | Common Stock | D | 14 | $42.31 - $42.31 | $592 |
| 2024-03-11 | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas R...
(CBO & EVP) |
S | Common Stock | D | 11509 | $49.93 - $49.93 | $574,644 |
| 2024-03-07 | Ultragenyx Pharmaceutical Inc. | Fust Matthew K
(Director) |
S | Common Stock | D | 12195 | $50.85 - $50.89 | $620,442 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Horn Howard
(Chief Financial Officer) |
A | Common Stock | A | 19400 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Parschauer Karah ...
(EVP and Chief Legal Officer) |
S | Common Stock | D | 3756 | $53.76 - $53.76 | $201,922 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Parschauer Karah ...
(EVP and Chief Legal Officer) |
A | Common Stock | A | 18757 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas R...
(CBO & EVP) |
S | Common Stock | D | 1011 | $53.76 - $53.76 | $54,351 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas R...
(CBO & EVP) |
F | Common Stock | D | 274 | $53.69 - $53.69 | $14,711 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Kassberg Thomas R...
(CBO & EVP) |
A | Common Stock | A | 18757 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl
(See Remarks) |
F | Common Stock | D | 470 | $53.69 - $53.69 | $25,234 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Huang Dennis Karl
(See Remarks) |
A | Common Stock | A | 18757 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Pinion John Richard
(See Remarks) |
S | Common Stock | D | 4173 | $53.76 - $53.76 | $224,340 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Pinion John Richard
(See Remarks) |
F | Common Stock | D | 60 | $53.69 - $53.69 | $3,221 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Pinion John Richard
(See Remarks) |
A | Common Stock | A | 18757 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
S | Common Stock | D | 341 | $53.76 - $53.76 | $18,332 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
F | Common Stock | D | 121 | $53.69 - $53.69 | $6,496 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
A | Common Stock | A | 13950 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Harris Erik
(EVP & Chief Commercial Officer) |
S | Common Stock | D | 4768 | $53.76 - $53.76 | $256,327 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | Harris Erik
(EVP & Chief Commercial Officer) |
A | Common Stock | A | 20357 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D
(President & CEO) |
F | Common Stock | D | 17417 | $53.69 - $53.69 | $935,118 |
| 2024-03-01 | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D
(President & CEO) |
A | Common Stock | A | 41560 | $0.00 - $0.00 | $0 |
| 2024-02-07 | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D
(President & CEO) |
S | Common Stock | D | 30000 | $45.00 - $45.00 | $1,350,000 |
| 2023-12-29 | Ultragenyx Pharmaceutical Inc. | KAKKIS EMIL D
(President & CEO) |
S | Common Stock | D | 30000 | $47.87 - $47.87 | $1,436,100 |
| 2024-01-02 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
M | Common Stock | A | 3000 | $21.00 - $21.00 | $63,000 |
| 2023-12-20 | Ultragenyx Pharmaceutical Inc. | Huizenga Theodore...
(SVP, Chief Accounting Officer) |
A | Common Stock | A | 1000 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |